Overdose Prevention Strategies
In states’ and communities’ efforts to identify and implement effective strategies to prevent and reduce opioid abuse and its consequences, it is critical for these efforts to be locally informed and responsive to local conditions and trends. As part of Vermont’s Prescription Drug Overdose Prevention grant funded by the Centers for Disease Control and Prevention (CDC), the Pacific Institute for Research and Evaluation (PIRE) is working with the Vermont Department of Health (VDH) to conduct 90 in-depth qualitative interviews with persons who use opioids and a variety of other state and local stakeholders (i.e., harm reduction professionals, those working at agencies that provide behavioral services, treatment providers) to assess current harm reduction strategies in use across Vermont. Specifically, the project is examining which harm reduction strategies Vermont residents are using (i.e., both services at local harm reduction agencies and behavioral strategies) to lower their risk of opioid-related overdose and transmission/acquisition of infectious diseases; gaps in knowledge; and facilitators and barriers to use of harm reduction services and strategies (e.g., naloxone, syringe services programs, and medication-assisted treatment). The findings will inform strategies that VDH and other agencies can use to effectively communicate health messages to persons who use opioids who are at increased risk and to the general public. This session will discuss findings in the context of recent and emerging drug use trends in the state and provide details about successful and promising approaches to harm reduction in Vermont.
This session is accredited for the following accreditation types: CME, CNE, CPE, APA, AAFP, AAHCPAD*, NAADAC*, ASWB*
*State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.